Navigation Links
Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
Date:7/29/2008

Newly enhanced Web site designed as an easy-to-navigate tool for consumers Web site developed with recommendations and feedback from an expert in the

field of ADHD

PHILADELPHIA, July 29 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced today the re-launch of its educational Web site, ADHDSupport.com, designed to provide families, caregivers, educators and patients with tools and resources about Attention Deficit Hyperactivity Disorder (ADHD). The newly enhanced ADHDSupport.com provides visitors with some information about the evaluation process and management of the disorder, as well as tools and practical tips to help patients with ADHD manage their daily activities.

"ADHD is a common psychiatric disorder that can impact the lives of many people, including patients, caregivers, friends and co-workers. It has certainly impacted my own life both personally and professionally," said Michele Novotni, Ph.D., internationally recognized ADHD expert, former president and CEO of the national Attention Deficit Disorder Association (ADDA), psychologist and consultant in the development of ADHDSupport.com. "Because I have seen the pain of unrealized dreams and untapped potential first-hand among those with ADHD, I am passionate about providing information about ADHD in easily accessible formats. In fact, there are many people who do not realize that they or their children may have ADHD and many are unaware of the resources available to help individuals with ADHD find out more about the disorder. After reviewing ADHDSupport.com from a clinical and personal perspective, I can confirm that the Web site is a helpful tool for support and information about ADHD."

The re-designed ADHDSupport.com provides visitors, especially those who may be new to ADHD, with an easy-to-navigate road map to help learn about ADHD and finding daily successes while living
'/>"/>

SOURCE Shire Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , BOSTON, Nov. 25 ...e H1N1 virus, genomic data from the 1918 pandemic ...the current H1N1 pandemic, today issued its latest...hows that the lethality of the H1N1 ("Swine Flu") ...during the virus,s current outbreak in the spring ...
(Date:11/25/2009)..., , ,, BOCA RATON, ... 2009 has been a painful year. Not so for BodyLogi...work of expert physicians specializing exclusively...as grown the number of physicians in its netwo...ns - and is in progress to add more physician-own...
(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswir...developer and provider of vaccines, announced toda...to establish Sinovac (Dalian) Vaccine,Technology C...evelop, produce,and commercialize human-use vaccin...rience in developing and commercializing world-cla...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-FirstC...nnounced today that Barry D. Quart, Pharm.D., pres... the Piper Jaffray 21st Annual Health Care Confere...er Jaffray 21st Annual Health Care Conference,Date....m. Eastern Time,Location: The New York Palace Ho...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...on Monday, February 25, 2008 at ...Biopharmaceuticals,Inc. (Nasdaq: KERX ), a biopha...velopment and commercialization of medically impor...nt of life-threatening,diseases, including diabete...results for the fourth quarter and year ended Dece...
...ht,Corporation (Nasdaq: PHST ), a leading provide...y services for optimizing clinical drug,developmen...sup and,Lamont,s 2008 Emerging Growth Stock Confer...mporary resort in Orlando, FL. Shawn O,Connor, Pha... Senior Vice President and CFO,will present the co...
...International, Inc. (Pink Sheets: BCLN) announced ...nvestment forum presented by Bluechip Capital,Inc....Mission Bay Hilton in,San Diego, California., Jam...rnational stated:,"The Bluechip Capital investment...present our compelling story to the investor commu...
Other Biology Technology:Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results 6Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference 2Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum 2Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum 3
(Date:11/26/2009)... What are the bare essentials of life, the indisp...t can survive on its own? Can we describe the mole...ire organism functions as a system? These are just...rship between the European Molecular Biology Labor...e de Regulacio Genmica (CRG) in Barcelona, Spain, ...
(Date:11/25/2009)...e California Institute of Technology (Caltech) hav...ehavior in the fruit fly, Drosophila melanogaster...e relationship between the neurotransmitter dopami...DHD), are described in the December issue of the j...ns only about 20,000 neurons and has long been con...
(Date:11/25/2009)... easy lives. In addition to mammalian immune syste...s called bacteriophages, viruses that kill half th...cteria and another class of microorganisms called ...such as deep-sea volcanic vents) manage just fine,...efense system that helps protect them from many vi...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 1Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 3Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 4
...pean BioAlpine Convention 2008, an international e...luster Rhne-Alpes (France), Piemonte (Italy) and ...rs and professionals from academia and industry in...ings in the fields of Bioinformatics and Proteomic...s in the technology and application of proteomics ...
...IRREGULAR HEARTBEAT MAY DEVELOP AFTER LUNG TRANSPL...atients receiving donated lungs may develop arrhyt...from Baylor College of Medicine in Texas reviewed ...06 and 2007. Of the 75 patients who underwent lung...in 30 days of transplantation. The most common arr...
...E, Mass. -- Drawing on records dating back to the ...vard University have found that different plant fa...climate change in strikingly different ways. Some ...g have included beloved species like lilies, orchi...ars this week in the Proceedings of the National ...
Other Biology News:Bridging public and private research on bioinformatics and proteomics 2New cardiology research presented at CHEST 2008 2New cardiology research presented at CHEST 2008 3New cardiology research presented at CHEST 2008 4Effects of climate change vary greatly across plant families 2
Anti-AANAT Antibody, Unconjugated from CHEMICON
Mouse Anti-TUP1 Monoclonal Antibody, Unconjugated, Clone 10 from Exalpha Biologicals, Inc.
Mouse Anti-Human NANS Monoclonal Antibody, Unconjugated, Clone 3G6 from ABR-Affinity BioReagents
Mouse Anti-C2 Monoclonal Antibody, Unconjugated, Clone 050-04 from Abcam
Biology Products: